Multinational Pharmaceutical Companies That Took the Mockery Lying Down
The Eagle Country, FDA headquarters.
The person in charge Davis, also received a mysterious phone call.
After saying a few words, he couldn't help but let out a strange laugh.
"Sanqing Group has only published one paper. Even if it's a breakthrough, it's still theoretical research and far from clinical trials. You don't need to make such a fuss."
A deep, dismissive voice came through the phone.
"Foolish! I have inside information that Three Purities has already applied for Phase I Clinical Trial of Neural Regeneration Factor."
Davis froze instantly, as if he had heard the biggest joke in the world, and shouted loudly.
"What? You're not kidding, are you?"
"They've only just published a theoretical paper, how can they have clinical results so quickly?"
"Heh, why would I lie to you? If you understand Chinese, you can just search it on the website of the China Drug Administration Bureau," the other person sneered.
Davis's voice immediately softened, and his heart pounded.
On one hand, there was shock; on the other hand, there was naturally panic.
But he remained defiant, saying, "I cannot believe it until there is evidence."
The other party sneered, "I'm not here to persuade you, I'm here to give you orders."
"Do you remember the huge investments we made in the field of neuroscience when the AD Special Effect Drug first came out?"
"These major pharmaceutical companies are simply a bunch of useless idiots. They've poured hundreds of millions of dollars into it; surely they should have made some progress by now, but they haven't made a single step forward. Instead, Three Purities has taken the lead. Bah!"
He issued the order in an unquestionable tone, with absolute force.
"Contact the heads of all pharmaceutical companies, including Pfizer, Roche, and Johnson & Johnson, immediately!"
"Have them come here immediately and start the battle right away. We must develop the drug that stimulates the regeneration of Neural Stem Cells as soon as possible!"
"Now that Three Purities has already developed the theory for them, the regulatory genes have been written out, and the drug targets are clear, the difficulties that follow can't be any greater than this."
"I hope you bunch of good-for-nothings won't disappoint me again."
With a click, the phone was disconnected.
Davis took a deep breath and shouted excitedly, "Get all those bastards from the pharmaceutical companies here immediately! Anyone who's late is fired! Don't expect us to give them any special treatment in drug approvals in the future."
When the subordinates saw their boss get angry, they didn't dare to be negligent and immediately notified all the pharmaceutical companies, big and small, in the Eagle Country.
Three hours later.
A spacious meeting room at FDA headquarters.
Executives from top pharmaceutical companies such as Johnson & Johnson, Pfizer, Roche arrived at the venue in a hurry.
Davis looked around and saw that almost everyone had arrived.
He went straight to the point, asking sternly, "I want to know, what progress have your pharmaceutical companies and laboratories made in this research on Neural Stem Cells regeneration?"
The pharmaceutical company executives looked at each other, their faces full of worry.
"Mr. Davis!" The Pfizer representative said with some excitement, "Brain Neural Stem Cell Regeneration Technology has made breakthroughs in China, but unfortunately, our laboratory has encountered difficulties and has not yet been able to break through the technical barriers and make substantial progress."
"Yes, so do we."
Seeing that Pfizer had conceded defeat, the other executives exchanged glances and began to complain.
"The mysteries of the brain are truly profound. Since the launch of the Three Purities AD Special Effect Drug, we at Roche immediately assembled a Neuroscience team of nearly 30 experts in related fields. After three years of continuous research, we still made no progress."
"We have even figured out the specific ingredients of the AD Special Effect Drug and developed a method to replicate it, but that is far from enough."
"Facts slapped us hard in the face. Our so-called efforts were worthless in front of the geniuses of Three Purities. After years of painstaking research, we couldn't even get a glimpse of their exhaust fumes."
Another pharmaceutical company executive said with a helpless, bitter smile.
The research failures of one top pharmaceutical company after another instantly plunged the entire conference room into an atmosphere of shock and fear.
Davis turned pale and exclaimed, "What if we gave you more time?"
"Could we make a breakthrough based on Three Purities's paper and develop a drug that stimulates brain nerve regeneration?"
"I'm afraid... it's very difficult, extremely difficult!"
The head of Roche lowered his head, unable to meet Davis's gaze.
"As everyone knows, it is extremely difficult to go from a theoretical breakthrough to a clinical breakthrough. It takes a lot of time and effort. It often takes at least 10 years for a theory to be put into practice, and that is considered fast."
"And the brain is the most difficult area of biology to tackle. Even if you invest in a research team of hundreds of people and spend 10 years, you may not be able to successfully develop a drug."
"Such a waste of effort is fatal for a company. Nowadays, large pharmaceutical companies are mainly driven by commercial interests, and no pharmaceutical company would do such a loss-making business. This resolution will not pass even at the board level."
Davis stared coldly at the person in charge who kept pouring cold water on him, feeling a surge of resentment and a sudden sense of frustration at his son's lack of ambition.
He recalled the call from the mysterious department, and finally agreed with their assessment of the group of useless people in front of him.
So he dropped the final bomb.
To ignite the last vestige of fighting spirit in this group.
"But Sanqing Group has already developed a drug that stimulates the regeneration of Neural Stem Cells and is conducting clinical trials in China."
"What!"
"That's impossible!"
"This is not scientific!"
Everyone gasped in unison, stunned into silence.
Immediately, the Roche representative stated decisively, "Ladies and gentlemen, we at Roche announce that we are abandoning the development of this brain cell regeneration drug."
"We at Johnson & Johnson have also announced the termination of our research and development work on this drug, as it did not meet our efficiency and expectations."
A group of pharmaceutical company executives expressed their opinions.
Upon hearing this, Davis staggered and nearly fell to the ground.
This is completely different from what he imagined.
These pharmaceutical bloodsuckers are truly despicable; they only know how to bully the weak and fear the strong, picking on the easy targets.
He thought bitterly to himself, but he was still somewhat unwilling to give up.
"What if other research departments were to get involved? Could they develop a drug similar to Three Purities?"
"Extremely difficult."
Everyone shook their heads like rattles.
"Even the top laboratories of research institutions such as Harvard, Stanford, and Hopkins University are not much different from the research and development of our pharmaceutical companies. It is actually difficult to exert efforts in such a completely new research direction."
"After all, this wasn't something they researched on their own; they were just following in others' footsteps, building upon their research findings. Their speed was definitely slower than that of the Three Purities."
"Once Three Purities publishes its patent, we will have access to detailed technical information, which may allow us to develop an improved drug."
"Developing it from scratch would be too difficult. We really can't do it."
The Pfizer representative said with a bitter expression.
A pharmaceutical group that wields immense influence in the pharmaceutical industry is being trampled underfoot by a China pharmaceutical company. It must feel uncomfortable, but it can only face the harsh reality.
"I'm sorry, Mr. Davis, our capabilities are limited."
After finishing their remarks, the pharmaceutical company representatives took their leave one after another.
Davis looked gloomy and slumped into a chair, feeling utterly powerless.
"We can only place our hopes on academia. They seem to have more interest in this than industry. Hopefully, they can come up with something."
In truth, he had no hope for it anymore.
It's always good for people to have dreams; what if they actually come true?